Investor's Business Daily on MSN
AbbVie Beats Third-Quarter Forecasts As Immunology Kingpin Grows 47%
AbbVieABBV leaned hard on Skyrizi, Rinvoq and Botox to offset continued steep declines from Humira and its aesthetics ...
Detailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback